Sustained delivery of dibutyryl cyclic adenosine monophosphate to the transected spinal cord via oligo [(polyethylene glycol) fumarate] hydrogels

Tissue Engineering - Part A

Volumn 17, Issue 9-10, 2011, Pages 1287-1302

  Rooney, Gemma E ^a   Knight, Andrew M ^a   Madigan, Nicolas N ^a,b   Gross, Louann ^a   Chen, Bingkun ^a   Giraldo, Catalina Vallejo ^a   Seo, Seungmae ^a   Nesbitt, Jarred J ^a   Dadsetan, Mahrokh ^a   Yaszemski, Michael J ^a   Windebank, Anthony J ^a  

^a Mayo Clinic College of Medicine   (United States)

^b NATIONAL UNIVERSITY OF IRELAND   (Ireland)

Author keywords

[No Author keywords available]

Indexed keywords

CELL CULTURE; DOSIMETRY; FETAL MONITORING; FLOWCHARTING; HYDROGELS; MICROSPHERES; NEURONS; POLYETHYLENE GLYCOLS; POLYETHYLENE OXIDES; POLYETHYLENES; STEM CELLS; THERMOPLASTICS;

AXONAL REGENERATION; CAPILLARY FORMATION; DELIVERY MECHANISM; DIBUTYRYL CYCLIC ADENOSINE MONOPHOSPHATE; FUMARATES; HYDROGEL SCAFFOLDS; IN-VITRO; MESENCHYMAL STEM CELL; NEURITE OUTGROWTH; PC12 CELLS; PLGA MICROSPHERES; POLY(LACTIC-CO-GLYCOLIC ACID); PROLONGED RELEASE; SCHWANN CELLS; SPINAL CORDS; THERAPEUTIC AGENTS;

SCAFFOLDS (BIOLOGY);

BIOMATERIAL; BUCLADESINE; FUMARIC ACID DERIVATIVE; LACTIC ACID; MACROGOL DERIVATIVE; MICROSPHERE; POLYGLYCOLIC ACID; POLYLACTIC ACID POLYGLYCOLIC ACID COPOLYMER; POLYLACTIC ACID-POLYGLYCOLIC ACID COPOLYMER;

ANIMAL; ARTICLE; CHEMISTRY; DELAYED RELEASE FORMULATION; HYDROGEL; METABOLISM; METHODOLOGY; NERVE FIBER; PATHOLOGY; RAT; SPINAL CORD; SPINAL CORD INJURY; SPRAGUE DAWLEY RAT; TISSUE REGENERATION;

ANIMALS; AXONS; BIOCOMPATIBLE MATERIALS; BUCLADESINE; DELAYED-ACTION PREPARATIONS; FUMARATES; GUIDED TISSUE REGENERATION; HYDROGELS; LACTIC ACID; MICROSPHERES; POLYETHYLENE GLYCOLS; POLYGLYCOLIC ACID; RATS; RATS, SPRAGUE-DAWLEY; SPINAL CORD; SPINAL CORD INJURIES;

EID: 79955022803     PISSN: 19373341     EISSN: 1937335X     Source Type: Journal    
DOI: 10.1089/ten.tea.2010.0396     Document Type: Article

References (87)

1. Quencer, R.M., and Bunge, R.P. The injured spinal cord: imaging, histopathologic clinical correlates, and basic science approaches to enhancing neural function after spinal cord injury. Spine 21, 2064, 1996
2. Bodley, R. Imaging in chronic spinal cord injury-indications and benefits. Eur J Radiol 42, 135, 2002
3. Tadie, M., Liu, S., Robert, R., Guiheneuc, P., Pereon, Y., Perrouin-Verbe, B., and Mathe, J.F. Partial return of motor function in paralyzed legs after surgical bypass of the lesion site by nerve autografts three years after spinal cord injury. J Neurotrauma 19, 909, 2002
4. Murphy, W., Peters, M., Kohn, D., and Mooney, D. Sustained release of vascular endothelial growth factor from mineralized poly(lactide-co-glycolide) scaffolds for tissue engineering. Biomaterials 21, 2521, 2000
5. Lu, L., Zhu, X., Valenzuela, R., Currier, B., and Yaszemski, M. Biodegradable polymer scaffolds for cartilage tissue engineering. Clin Orthop 391, S251, 2001
6. Maquet, V., Martin, D., Scholtes, F., Franzen, R., Schoenen, J., Moonen, G., and Jerme, R. Poly(D,L-lactide) foams modified by poly(ethylene oxide)-block-poly(D,L-lactide) copolymers and a-FGF: in vitro and in vivo evaluation for spinal cord regeneration. Biomaterials 22, 1137, 2001
7. Jain, R. The manufacturing techniques of various drug loaded biodegradable poly(lactide-co-glycolide) (PLGA) devices. Biomaterials 21, 2475, 2000
8. Eliaz, R., Wallach, D., and Kost, J. Delivery of soluble tumor necrosis factor receptor from in-situ forming PLGA implants: in-vivo. Pharm Res 17, 1546, 2000
9. Gumusderelioglu, M., and Deniz, G. Sustained release of mitomycin-C from poly(dl-lactide)/poly(dl-lactide-coglycolide) films. J Biomater Sci Polym Ed 11, 1039, 2000
10. Xu, X., Yee, W.C., Hwang, P.Y., Yu, H., Wan, A.C., Gao, S., Boon, K.L., Mao, H.Q., Leong, K.W., and Wang, S. Peripheral nerve regeneration with sustained release of poly(phosphoester) microencapsulated nerve growth factor within nerve guide conduits. Biomaterials 24, 2405, 2003
11. Friedman, J., Windebank, A., Moore, M., Spinner, R., Currier, B., and Yazemski, M. Biodegradeable polymer grafts for surgical repair of the injured spinal cord. Neurosurgery 51, 742, 2002
12. Bunge, M. Bridging areas of injury in the spinal cord. Neuroscientist 7, 325, 2001
13. Bunge, M.B. Bridging the transected or contused adult rat spinal cord with Schwann cell and olfactory ensheathing glia transplants. Prog Brain Res 137, 275, 2002
14. Takami, T., Oudega, M., Bates, M.L., Wood, P.M., Kleitman, N., and Bunge, M.B. Schwann cell but not olfactory ensheathing glia transplants improve hindlimb locomotor performance in the moderately contused adult rat thoracic spinal cord. J Neurosci 22, 6670, 2002
15. Novikova, L.N., Novikov, L.N., and Kellerth, J.O. Biopolymers and biodegradable smart implants for tissue regeneration after spinal cord injury. Curr Opin Neurol 16, 711, 2003
16. Novikova, L.N., Pettersson, J., Brohlin, M., Wiberg, M., and Novikov, L.N. Biodegradable poly-beta-hydroxybutyrate scaffold seeded with Schwann cells to promote spinal cord repair. Biomaterials 29, 1198, 2008
17. Rosenzweig, E.S., and McDonald, J.W. Rodent models for treatment of spinal cord injury: research trends and progress toward useful repair. Curr Opin Neurol 17, 121, 2004
18. Xu, X.M., Guenard, V., Kleitman, N., and Bunge, M.B. Axonal regeneration into Schwann cell-seeded guidance channels grafted into transected adult rat spinal cord. J Comp Neurol 351, 145, 1995
19. Moore, M.J., Friedman, J.A., Lewellyn, E.B., Mantila, S.M., Krych, A.J., Ameenuddin, S., Knight, A.M., Lu, L., Currier, B.L., Spinner, R.J., Marsh, R.W., Windebank, A.J., and Yaszemski, M.J. Multiple-channel scaffolds to promote spinal cord axon regeneration. Biomaterials 27, 419, 2006
20. Friedman, J.A., Windebank, A.J., Moore, M.J., Spinner, R.J., Currier, B.L., and Yaszemski, M.J. Biodegradable polymer grafts for surgical repair of the injured spinal cord. Neurosurgery 51, 742, 2002
21. Jo, S., Shin, H., and Mikos, A.G. Modification of oligo(poly(ethylene glycol) fumarate) macromer with a GRGD peptide for the preparation of functionalized polymer networks. Biomacromolecules 2, 255, 2001
22. Shin, H., Quinten Ruhe, P., Mikos, A.G., and Jansen, J.A. In vivo bone and soft tissue response to injectable, biodegradable oligo(poly(ethylene glycol) fumarate) hydrogels. Biomaterials 24, 3201, 2003
23. Temenoff, J.S., Athanasiou, K.A., LeBaron, R.G., and Mikos, A.G. Effect of poly(ethylene glycol) molecular weight on tensile and swelling properties of oligo(poly(ethylene glycol) fumarate) hydrogels for cartilage tissue engineering. J Biomed Mater Res 59, 429, 2002
24. Temenoff, J.S., Steinbis, E.S., and Mikos, A.G. Effect of drying history on swelling properties and cell attachment to oligo(poly(ethylene glycol) fumarate) hydrogels for guided tissue regeneration applications. J Biomater Sci Polym Ed 14, 989, 2003
25. Shin, H., Jo, S., and Mikos, A.G. Modulation of marrow stromal osteoblast adhesion on biomimetic oligo[poly (ethylene glycol) fumarate] hydrogels modified with Arg- Gly-Asp peptides and a poly(ethyleneglycol) spacer. J Biomed Mater Res 61, 169, 2002
26. Shin, H., Zygourakis, K., Farach-Carson, M.C., Yaszemski, M.J., and Mikos, A.G. Attachment, proliferation, and migration of marrow stromal osteoblasts cultured on biomimetic hydrogels modified with an osteopontin-derived peptide. Biomaterials 25, 895, 2004
27. Dadsetan, M., Hefferan, T.E., Szatkowski, J.P., Mishra, P.K., Macura, S.I., Lu, L., and Yaszemski, M.J. Effect of hydrogel porosity on marrow stromal cell phenotypic expression. Biomaterials 29, 2193, 2008
28. Shin, H., Temenoff, J.S., Bowden, G.C., Zygourakis, K., Farach-Carson, M.C., Yaszemski, M.J., and Mikos, A.G. Osteogenic differentiation of rat bone marrow stromal cells cultured on Arg-Gly-Asp modified hydrogels without dexamethasone and beta-glycerol phosphate. Biomaterials 26, 3645, 2005
29. Shin, H., Zygourakis, K., Farach-Carson, M.C., Yaszemski, M.J., and Mikos, A.G. Modulation of differentiation and mineralization of marrow stromal cells cultured on biomimetic hydrogels modified with Arg-Gly-Asp containing peptides. J Biomed Mater Res A 69, 535, 2004
30. Temenoff, J.S., Park, H., Jabbari, E., Conway, D.E., Sheffield, T.L., Ambrose, C.G., and Mikos, A.G. Thermally crosslinked oligo(poly(ethylene glycol) fumarate) hydrogels support osteogenic differentiation of encapsulated marrow stromal cells in vitro. Biomacromolecules 5, 5, 2004
31. Temenoff, J.S., Park, H., Jabbari, E., Sheffield, T.L., LeBaron, R.G., Ambrose, C.G., and Mikos, A.G. In vitro osteogenic differentiation of marrow stromal cells encapsulated in biodegradable hydrogels. J Biomed Mater Res A 70, 235, 2004
32. Dadsetan, M., Szatkowski, J.P., Yaszemski, M.J., and Lu, L. Characterization of photo-cross-linked oligo[poly(ethylene glycol) fumarate] hydrogels for cartilage tissue engineering. Biomacromolecules 8, 1702, 2007
33. Kasper, F.K., Jerkins, E., Tanahashi, K., Barry, M.A., Tabata, Y., and Mikos, A.G. Characterization of DNA release from composites of oligo(poly(ethylene glycol) fumarate) and cationized gelatin microspheres in vitro. J Biomed Mater Res A 78, 823, 2006
34. Kasper, F.K., Kushibiki, T., Kimura, Y., Mikos, A.G., and Tabata, Y. In vivo release of plasmid DNA from composites of oligo(poly(ethylene glycol)fumarate) and cationized gelatin microspheres. J Control Release 107, 547, 2005
35. Holland, T.A., Tabata, Y., and Mikos, A.G. Dual growth factor delivery from degradable oligo(poly(ethylene glycol) fumarate) hydrogel scaffolds for cartilage tissue engineering. J Control Release 101, 111, 2005
36. Dadsetan, M., Knight, A.M., Lu, L., Windebank, A.J., and Yaszemski, M.J. Stimulation of neurite outgrowth using positively charged hydrogels. Biomaterials 30, 3874, 2009
37. Rooney, G.E., Moran, C., McMahon, S.S., Ritter, T., Maenz, M., Flugel, A., Dockery, P., O'Brien, T., Howard, L., Windebank, A.J., and Barry, F.P. Gene-modified mesenchymal stem cells express functionally active nerve growth factor on an engineered poly lactic glycolic acid (PLGA) substrate. Tissue Eng Part A 14, 681, 2008
38. Wu, X.S., and Wang, N. Synthesis, characterization, biodegradation, and drug delivery application of biodegradable lactic/glycolic acid polymers. Part II: biodegradation. J Biomater Sci Polym Ed 12, 21, 2001
39. Cohen, S., Yoshioka, T., Lucarelli, M., Hwang, L.H., and Langer, R. Controlled delivery systems for proteins based on poly(lactic/glycolic acid) microspheres. Pharm Res 8, 713, 1991
40. Bilati, U., Allemann, E., and Doelker, E. Development of a nanoprecipitation method intended for the entrapment of hydrophilic drugs into nanoparticles. Eur J Pharm Sci 24, 67, 2005
41. Lee, J., and Lee, K.Y. Local and sustained vascular endothelial growth factor delivery for angiogenesis using an injectable system. Pharm Res 26, 1739, 2009
42. Wang, X.,Wenk, E., Zhang, X., Meinel, L., Vunjak-Novakovic, G., and Kaplan, D.L. Growth factor gradients via microsphere delivery in biopolymer scaffolds for osteochondral tissue engineering. J Control Release 134, 81, 2009
43. Jaklenec, A., Hinckfuss, A., Bilgen, B., Ciombor, D.M., Aaron, R., and Mathiowitz, E. Sequential release of bioactive IGF-I and TGF-beta 1 from PLGA microsphere-based scaffolds. Biomaterials 29, 1518, 2008
44. Jiang, W., Gupta, R.K., Deshpande, M.C., and Schwendeman, S.P. Biodegradable poly(lactic-co-glycolic acid) microparticles for injectable delivery of vaccine antigens. Adv Drug Deliv Rev 57, 391, 2005
45. Jaklenec, A., Wan, E., Murray, M.E., and Mathiowitz, E. Novel scaffolds fabricated from protein-loaded microspheres for tissue engineering. Biomaterials 29, 185, 2008
46. Kasper, F.K., Seidlits, S.K., Tang, A., Crowther, R.S., Carney, D.H., Barry, M.A., and Mikos, A.G. In vitro release of plasmid DNA from oligo(poly(ethylene glycol) fumarate) hydrogels. J Control Release 104, 521, 2005
47. Rydel, R.E., and Greene, L.A. cAMP analogs promote survival and neurite outgrowth in cultures of rat sympathetic and sensory neurons independently of nerve growth factor. Proc Natl Acad Sci USA 85, 1257, 1988
48. Meyer-Franke, A., Kaplan, M.R., Pfrieger, F.W., and Barres, B.A. Characterization of the signaling interactions that promote the survival and growth of developing retinal ganglion cells in culture. Neuron 15, 805, 1995
49. Song, H.J., Ming, G.L., and Poo, M.M. cAMP-induced switching in turning direction of nerve growth cones. Nature 388, 275, 1997
50. Kao, H.T., Song, H.J., Porton, B., Ming, G.L., Hoh, J., Abraham, M., Czernik, A.J., Pieribone, V.A., Poo, M.M., and Greengard, P. A protein kinase A-dependent molecular switch in synapsins regulates neurite outgrowth. Nat Neurosci 5, 431, 2002
51. Pearse, D.D., Pereira, F.C., Marcillo, A.E., Bates, M.L., Berrocal, Y.A., Filbin, M.T., and Bunge, M.B. cAMP and Schwann cells promote axonal growth and functional recovery after spinal cord injury. Nat Med 10, 610, 2004
52. Lu, P., Yang, H., Jones, L.L., Filbin, M.T., and Tuszynski, M.H. Combinatorial therapy with neurotrophins and cAMP promotes axonal regeneration beyond sites of spinal cord injury. J Neurosci 24, 6402, 2004
53. Neumann, S., Bradke, F., Tessier-Lavigne, M., and Basbaum, A.I. Regeneration of sensory axons within the injured spinal cord induced by intraganglionic cAMP elevation. Neuron 34, 885, 2002
54. Qiu, J., Cai, D., Dai, H., McAtee, M., Hoffman, P.N., Bregman, B.S., and Filbin, M.T. Spinal axon regeneration induced by elevation of cyclic AMP. Neuron 34, 895, 2002
55. Deshpande, D.M., Kim, Y.S., Martinez, T., Carmen, J., Dike, S., Shats, I., Rubin, L.L., Drummond, J., Krishnan, C., Hoke, A., Maragakis, N., Shefner, J., Rothstein, J.D., and Kerr, D.A. Recovery from paralysis in adult rats using embryonic stem cells. Ann Neurol 60, 32, 2006
56. de Boer, R., Knight, A.M., Spinner, R.J., Malessy, M., Yaszemski, M.J., and Windebank, A.J. In vitro and in vivo release of nerve growth factor from biodegradable poly-lactic-coglycolic- acid microspheres. J Biomed Mater Res Part A 95, 1067, 2010
57. Rooney, G.E., McMahon, S.S., Ritter, T., Garcia, Y., Moran, C., Madigan, N.N., Fluegel, A., Dockery, P., O'Brien, T., Howard, L., Windebank, A.J., and Barry, F. Neurotrophic factor-expressing mesenchymal stem cells survive transplantation into the contused spinal cord without differentiating into neural cells. Tissue Eng Part A 15, 3049, 2009
58. Olson, H.E., Rooney, G.E., Gross, L., Nesbitt, J.J., Galvin, K.E., Knight, A., Chen, B., Yaszemski, M.J., and Windebank, A.J. Neural stem cell- and Schwann cell-loaded biodegradable polymer scaffolds support axonal regeneration in the transected spinal cord. Tissue Eng Part A 15, 1797, 2009
59. Krych, A.J., Rooney, G.E., Chen, B., Schermerhorn, T.C., Ameenuddin, S., Gross, L., Moore, M.J., Currier, B.L., Spinner, R.J., Friedman, J.A., Yaszemski, M.J., and Windebank, A.J. Relationship between scaffold channel diameter and number of regenerating axons in the transected rat spinal cord. Acta Biomater 5, 2551, 2009
60. Chen, B.K., Knight, A.M., de Ruiter, G.C., Spinner, R.J., Yaszemski, M.J., Currier, B.L., and Windebank, A.J. Axon regeneration through scaffold into distal spinal cord after transection. J Neurotrauma 26, 1759, 2009
61. Gysbers, J.W., and Rathbone, M.P. Neurite outgrowth in PC12 cells is enhanced by guanosine through both cAMPdependent and -independent mechanisms. Neurosci Lett 220, 175, 1996
62. Shimomura, A., Okamoto, Y., Hirata, Y., Kobayashi, M., Kawakami, K., Kiuchi, K., Wakabayashi, T., and Hagiwara, M. Dominant negative ATF1 blocks cyclic AMP-induced neurite outgrowth in PC12D cells. J Neurochem 70, 1029, 1998
63. Kano, Y., Nohno, T., Takahashi, R., Hasegawa, T., Hiragami, F., Kawamura, K., Motoda, H., and Sugiyama, T. cAMP and calcium ionophore induce outgrowth of neuronal processes in PC12 mutant cells in which nerve growth factor-induced outgrowth of neuronal processes is impaired. Neurosci Lett 303, 21, 2001
64. Piiper, A., Dikic, I., Lutz, M.P., Leser, J., Kronenberger, B., Elez, R., Cramer, H., Muller-Esterl, W., and Zeuzem, S. Cyclic AMP induces transactivation of the receptors for epidermal growth factor and nerve growth factor, thereby modulating activation of MAP kinase, Akt, and neurite outgrowth in PC12 cells. J Biol Chem 277, 43623, 2002
65. Harper, J.M., Krishnan, C., Darman, J.S., Deshpande, D.M., Peck, S., Shats, I., Backovic, S., Rothstein, J.D., and Kerr, D.A. Axonal growth of embryonic stem cell-derived motoneurons in vitro and in motoneuron-injured adult rats. Proc Natl Acad Sci USA 101, 7123, 2004
66. Xu, X., Guenard, V., Kleitman, N., and Bunge, M. Axonal regeneration into Schwann cell-seeded guidance channels grafted into transected adult rat spinal cord. J Comp Neurol 351, 145, 1995
67. Oudega, M., Gautier, S.E., Chapon, P., Fragoso, M., Bates, M.L., Parel, J.M., and Bunge, M.B. Axonal regeneration into Schwann cell grafts within resorbable poly(alpha-hydroxyacid) guidance channels in the adult rat spinal cord. Biomaterials 22, 1125, 2001
68. Unsicker, K., and Chamley, J.H. Effects of dbcAMP and theophylline on rat adrenal medulla grown in tissue culture. Histochemistry 46, 197, 1976
69. Sobue, G., Shuman, S., and Pleasure, D. Schwann cell responses to cyclic AMP: proliferation, change in shape, and appearance of surface galactocerebroside. Brain Res 362, 23, 1986
70. Sobue, G., Yasuda, T., Mitsuma, T., and Pleasure, D. Schwann cell galactocerebroside of unmyelinated fibers is inducible by derivatives of adenosine 3',5'-monophosphate. Neurosci Lett 72, 253, 1986
71. Morgan, L., Jessen, K.R., and Mirsky, R. The effects of cAMP on differentiation of cultured Schwann cells: progression from an early phenotype (04 + ) to a myelin phenotype (P0 +, GFAP-, N-CAM-, NGF-receptor-) depends on growth inhibition. J Cell Biol 112, 457, 1991
72. Monje, P.V., Rendon, S., Athauda, G., Bates, M., Wood, P.M., and Bunge, M.B. Non-antagonistic relationship between mitogenic factors and cAMP in adult Schwann cell redifferentiation. Glia 57, 947, 2009
73. Yamamoto, M., Sobue, G., Li, M., Mitsuma, T., Kimata, K., and Yamada, Y. cAMP-dependent differential regulation of extracellular matrix (ECM) gene expression in cultured rat Schwann cells. Brain Res 653, 335, 1994
74. Suon, S., Jin, H., Donaldson, A.E., Caterson, E.J., Tuan, R.S., Deschennes, G., Marshall, C., and Iacovitti, L. Transient differentiation of adult human bone marrow cells into neuronlike cells in culture: development of morphological and biochemical traits is mediated by different molecular mechanisms. Stem Cells Dev 13, 625, 2004
75. Chu, M.S., Chang, C.F., Yang, C.C., Bau, Y.C., Ho, L.L., and Hung, S.C. Signalling pathway in the induction of neurite outgrowth in human mesenchymal stem cells. Cell Signal 18, 519, 2006
76. Zwart, I., Hill, A.J., Girdlestone, J., Manca, M.F., Navarrete, R., Navarrete, C., and Jen, L.S. Analysis of neural potential of human umbilical cord blood-derived multipotent mesenchymal stem cells in response to a range of neurogenic stimuli. J Neurosci Res 86, 1902, 2008
77. Rooney, G.E., Howard, L., O'Brien, T., Windebank, A.J., and Barry, F.P. Elevation of cAMP in mesenchymal stem cells transiently upregulates neural markers rather than inducing neural differentiation. Stem Cells Dev 18, 387, 2009. SUSTAINED RELEASE OF DBCAMP IN SPINAL CORD INJURY 1301
78. Fouad, K., Ghosh, M., Vavrek, R., Tse, A.D., and Pearse, D.D. Dose and chemical modification considerations for continuous cyclic AMP analog delivery to the injured CNS. J Neurotrauma 26, 733, 2009
79. Rooney, G.E., Endo, T., Ameenuddin, S., Chen, B., Vaishya, S., Gross, L., Schiefer, T.K., Currier, B.L., Spinner, R.J., Yaszemski, M.J., and Windebank, A.J. Importance of the vasculature in cyst formation after spinal cord injury. J Neurosurg Spine 11, 432, 2009
80. Norenberg, M.D., Smith, J., and Marcillo, A. The pathology of human spinal cord injury: defining the problems. J Neurotrauma 21, 429, 2004
81. Dumont, R.J., Okonkwo, D.O., Verma, S., Hurlbert, R.J., Boulos, P.T., Ellegala, D.B., and Dumont, A.S. Acute spinal cord injury, part I: pathophysiologic mechanisms. Clin Neuropharmacol 24, 254, 2001
82. Wu, Y., Chen, L., Scott, P.G., and Tredget, E.E. Mesenchymal stem cells enhance wound healing through differentiation and angiogenesis. Stem cells 25, 2648, 2007
83. Alviano, F., Fossati, V., Marchionni, C., Arpinati, M., Bonsi, L., Franchina, M., Lanzoni, G., Cantoni, S., Cavallini, C., Bianchi, F., Tazzari, P.L., Pasquinelli, G., Foroni, L., Ventura, C., Grossi, A., and Bagnara, G.P. Term amniotic membrane is a high throughput source for multipotent mesenchymal stem cells with the ability to differentiate into endothelial cells in vitro. BMC Dev Biol 7, 11, 2007
84. Duffy, G.P., Ahsan, T., O'Brien, T., Barry, F., and Nerem, R.M. Bone marrow-derived mesenchymal stem cells promote angiogenic processes in a time- and dose-dependent manner in vitro. Tissue Eng Part A 15, 2459, 2009
85. Huang, N.F., Lam, A., Fang, Q., Sievers, R.E., Li, S., and Lee, R.J. Bone marrow-derived mesenchymal stem cells in fibrin augment angiogenesis in the chronically infarcted myocardium. Regen Med 4, 527, 2009
86. Caplan, A.I. All MSCs are pericytes? Cell Stem Cell 3, 229, 2008
87. Crisan, M., Yap, S., Casteilla, L., Chen, C.W., Corselli, M., Park, T.S., Andriolo, G., Sun, B., Zheng, B., Zhang, L., Norotte, C., Teng, P.N., Traas, J., Schugar, R., Deasy, B.M., Badylak, S., Buhring, H.J., Giacobino, J.P., Lazzari, L., Huard, J., and Peault, B. A perivascular origin for mesenchymal stem cells in multiple human organs. Cell Stem Cell 3, 301, 2008